LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,115,774 | -23.0% | 135,443 | -7.3% | 0.00% | 0.0% |
| Q2 2023 | $10,533,378 | +8.0% | 146,094 | +10.2% | 0.00% | 0.0% |
| Q1 2023 | $9,748,797 | +8.0% | 132,528 | -1.9% | 0.00% | 0.0% |
| Q4 2022 | $9,023,000 | -27.2% | 135,077 | -6.2% | 0.00% | -40.0% |
| Q3 2022 | $12,402,000 | -7.4% | 144,013 | -4.1% | 0.01% | 0.0% |
| Q2 2022 | $13,393,000 | +6.9% | 150,132 | +34.8% | 0.01% | +25.0% |
| Q1 2022 | $12,525,000 | -27.6% | 111,348 | -0.6% | 0.00% | -20.0% |
| Q4 2021 | $17,305,000 | +12.2% | 112,050 | +1.2% | 0.01% | 0.0% |
| Q3 2021 | $15,425,000 | +29.0% | 110,726 | +21.5% | 0.01% | +25.0% |
| Q2 2021 | $11,956,000 | -14.9% | 91,136 | -1.1% | 0.00% | -20.0% |
| Q1 2021 | $14,053,000 | -16.0% | 92,158 | -45.2% | 0.01% | -16.7% |
| Q4 2020 | $16,725,000 | -15.0% | 168,169 | -18.5% | 0.01% | -25.0% |
| Q3 2020 | $19,670,000 | -61.5% | 206,354 | -54.8% | 0.01% | -63.6% |
| Q2 2020 | $51,121,000 | +112.2% | 456,626 | +37.8% | 0.02% | +69.2% |
| Q1 2020 | $24,096,000 | -25.0% | 331,361 | +7.6% | 0.01% | 0.0% |
| Q4 2019 | $32,132,000 | -2.8% | 308,034 | -7.2% | 0.01% | -13.3% |
| Q3 2019 | $33,043,000 | -7.3% | 331,972 | +6.3% | 0.02% | -6.2% |
| Q2 2019 | $35,648,000 | -14.2% | 312,343 | -5.5% | 0.02% | -15.8% |
| Q1 2019 | $41,568,000 | -55.3% | 330,640 | -51.8% | 0.02% | -59.6% |
| Q4 2018 | $93,084,000 | -47.4% | 685,998 | +6.5% | 0.05% | -24.2% |
| Q3 2018 | $176,857,000 | +11.6% | 644,312 | -15.8% | 0.06% | -11.4% |
| Q2 2018 | $158,519,000 | +24.2% | 765,169 | -0.9% | 0.07% | +20.7% |
| Q1 2018 | $127,586,000 | +128.7% | 772,494 | +89.6% | 0.06% | +132.0% |
| Q4 2017 | $55,777,000 | +6.7% | 407,372 | +6.1% | 0.02% | 0.0% |
| Q3 2017 | $52,272,000 | +21.5% | 383,919 | +8.4% | 0.02% | +13.6% |
| Q2 2017 | $43,012,000 | +13.9% | 354,299 | -0.7% | 0.02% | +10.0% |
| Q1 2017 | $37,774,000 | -11.1% | 356,870 | -14.6% | 0.02% | -13.0% |
| Q4 2016 | $42,470,000 | -3.6% | 417,966 | -3.1% | 0.02% | -8.0% |
| Q3 2016 | $44,039,000 | -9.1% | 431,480 | +6.1% | 0.02% | -10.7% |
| Q2 2016 | $48,435,000 | +16.2% | 406,729 | +4.5% | 0.03% | +12.0% |
| Q1 2016 | $41,693,000 | +18.7% | 389,327 | +20.2% | 0.02% | +19.0% |
| Q4 2015 | $35,126,000 | +27.7% | 323,985 | +0.8% | 0.02% | +23.5% |
| Q3 2015 | $27,515,000 | -21.6% | 321,266 | -7.7% | 0.02% | -15.0% |
| Q2 2015 | $35,104,000 | +36.9% | 347,920 | +4.6% | 0.02% | +33.3% |
| Q1 2015 | $25,637,000 | +277.2% | 332,462 | +160.3% | 0.02% | +275.0% |
| Q4 2014 | $6,796,000 | +17.0% | 127,704 | +3.3% | 0.00% | +33.3% |
| Q3 2014 | $5,810,000 | -36.3% | 123,661 | -15.6% | 0.00% | -40.0% |
| Q2 2014 | $9,124,000 | +15.3% | 146,478 | +24.5% | 0.01% | 0.0% |
| Q1 2014 | $7,910,000 | +49.2% | 117,611 | +16.7% | 0.01% | +66.7% |
| Q4 2013 | $5,300,000 | +411.6% | 100,772 | +320.7% | 0.00% | +200.0% |
| Q3 2013 | $1,036,000 | -49.0% | 23,956 | -55.9% | 0.00% | 0.0% |
| Q2 2013 | $2,031,000 | – | 54,273 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |